Free Trial

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems logo
$298.42 -3.38 (-1.12%)
Closing price 10/9/2025 03:59 PM Eastern
Extended Trading
$298.67 +0.25 (+0.08%)
As of 05:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
2
Hold
7
Buy
16

Based on 25 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 25 analysts, 2 have given a sell rating, 7 have given a hold rating, and 16 have given a buy rating for VEEV.

Consensus Price Target

$307.58
3.07% Upside
According to the 25 analysts' twelve-month price targets for Veeva Systems, the average price target is $307.58. The highest price target for VEEV is $380.00, while the lowest price target for VEEV is $200.00. The average price target represents a forecasted upside of 3.07% from the current price of $298.42.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VEEV Analyst Ratings Over Time

TypeCurrent Forecast
10/10/24 to 10/10/25
1 Month Ago
9/10/24 to 9/10/25
3 Months Ago
7/12/24 to 7/12/25
1 Year Ago
10/11/23 to 10/10/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
16 Buy rating(s)
17 Buy rating(s)
14 Buy rating(s)
16 Buy rating(s)
Hold
7 Hold rating(s)
6 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$307.58$301.48$271.04$232.96
Forecasted Upside3.07% Upside9.64% Upside-1.73% Downside10.86% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Veeva Systems Stock vs. The Competition

TypeVeeva SystemsMedical CompaniesS&P 500
Consensus Rating Score
2.56
2.33
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside3.07% Upside1,057.16% Upside172.89% Upside
News Sentiment Rating
Positive News

See Recent VEEV News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/8/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingHold (C+)
10/7/2025TD Cowen
4 of 5 stars
Charles Rhyee
Charles Rhyee
Not Rated
UpgradeHoldBuy$297.00 ➝ $380.00+26.73%
9/8/2025JPMorgan Chase & Co.
2 of 5 stars
Alexei Gogolev
Alexei Gogolev
Not Rated
UpgradeNeutralOverweight$290.00 ➝ $330.00+20.83%
8/29/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$295.00 ➝ $325.00+21.13%
8/28/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$329.00 ➝ $349.00+28.07%
8/28/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetHold$270.00 ➝ $300.00+8.72%
8/28/2025Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$325.00+17.60%
8/28/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetUnderweight$210.00 ➝ $222.00-20.49%
8/28/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$310.00 ➝ $340.00+22.10%
8/28/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$300.00 ➝ $325.00+15.67%
8/28/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$295.00 ➝ $320.00+15.67%
8/28/2025BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$335.00 ➝ $340.00+22.89%
8/28/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$285.00 ➝ $310.00+12.05%
8/28/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetHold$268.00 ➝ $275.00-6.85%
8/28/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetIn-Line$285.00 ➝ $295.00-0.08%
8/28/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$325.00 ➝ $355.00+20.25%
8/28/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$300.00 ➝ $355.00+20.25%
8/26/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$300.00 ➝ $326.00+14.17%
7/14/2025KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$285.00 ➝ $325.00+17.83%
3/6/2025Scotiabank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetSector Perform$240.00 ➝ $245.00+3.61%
3/6/2025Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$280.00 ➝ $280.00+19.63%
3/6/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$283.00 ➝ $285.00+29.36%
1/23/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuySell$261.00 ➝ $200.00-12.68%
12/6/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetNeutral$280.00 ➝ $290.00+13.44%
12/6/2024Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOutperform$275.00 ➝ $285.00+12.20%
10/8/2024BNP Paribas
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$286.00+41.70%
10/1/2024Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$233.00 ➝ $249.00+20.00%
3/4/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$225.00 ➝ $270.00+21.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:03 AM ET.


Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 8, 2025. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • The current stock price is around $296, reflecting a strong market position and investor interest in the company's growth potential.
  • Veeva Systems Inc. has a robust market capitalization of approximately $48.60 billion, indicating a solid financial foundation and stability in the technology sector.
  • Recent insider trading activity shows confidence from executives, with significant stock sales indicating liquidity and potential for reinvestment in growth initiatives.
  • Institutional investors hold a substantial 88.20% of the stock, suggesting strong backing from major financial entities, which can enhance market credibility.
  • Analyst ratings are predominantly positive, with a majority recommending a "Buy" rating, indicating strong future growth expectations for the company.

Veeva Systems
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • Insider sales have totaled over 18,000 shares recently, which could signal a lack of confidence in the stock's short-term performance.
  • The stock has experienced fluctuations, with a recent decline of about 1.4%, which may raise concerns about its volatility and market stability.
  • Despite a high market cap, the P/E ratio stands at 60.88, suggesting that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • Recent analyst reports have shown mixed sentiments, with some firms downgrading their ratings, indicating potential uncertainty in future performance.
  • Insider ownership is relatively low at 10.30%, which may imply less alignment between management and shareholder interests, potentially affecting long-term strategic decisions.

VEEV Forecast - Frequently Asked Questions

According to the research reports of 25 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $307.58, with a high forecast of $380.00 and a low forecast of $200.00.

25 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last year. There are currently 2 sell ratings, 7 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VEEV shares.

According to analysts, Veeva Systems's stock has a predicted upside of 3.07% based on their 12-month stock forecasts.

Over the previous 90 days, Veeva Systems's stock had 2 upgrades by analysts.

Analysts like Veeva Systems more than other "medical" companies. The consensus rating for Veeva Systems is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how VEEV compares to other companies.


This page (NYSE:VEEV) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners